ACCAHA更新瓣膜性疾病TAVI手术指

“DecidingonTAVIorSAVRdependsonpatient-specificfactors,includingtechnical,procedure-specificcontraindicationsandthebalancebetweenestimatedlifeexpectancyandanticipatedprosthesisdurability.Thesefactorspertaintothedecisionbetweenmechanicalandbiologicalprostheses,andifthechoiceisbiological,betweenSAVRandTAVI.Astrongemphasisisnowplacedonshareddecision-makingwiththepatientandinvolvementofthemultidisciplinaryheartteam.Formostpatientsyoungerthan65years,SAVRisre

转载请注明：http://www.ctongt.com/gbzl/8369.html

• 上一篇文章： 医界大咖联动探讨学术前沿献礼建党
  
• 下一篇文章： ldquoEHJ中文版心脏病学中外名